Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GALATEE: Lantus + Glucophage in T2D Responders
NCT00653302Phase 4Completed
- Sponsor
- Sanofi
- Start
- Apr 2003
- Primary completion
- Sep 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Apr 2003; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00653302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00653302.